Search

Ganapathy Krishnan

Examiner (ID: 6885, Phone: (571)272-0654 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1693, 1673
Total Applications
1710
Issued Applications
810
Pending Applications
207
Abandoned Applications
716

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19387875 [patent_doc_number] => 20240277745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => PEMAFIBRATE AND/OR TOFOGLIFLOZIN FOR USE IN TREATING LIVER DISEASE [patent_app_type] => utility [patent_app_number] => 18/564115 [patent_app_country] => US [patent_app_date] => 2022-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564115 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/564115
PEMAFIBRATE AND/OR TOFOGLIFLOZIN FOR USE IN TREATING LIVER DISEASE May 24, 2022 Pending
Array ( [id] => 19360821 [patent_doc_number] => 20240262855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => A Method For Producing Cationic Saccharides [patent_app_type] => utility [patent_app_number] => 18/565781 [patent_app_country] => US [patent_app_date] => 2022-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565781 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/565781
A Method For Producing Cationic Saccharides May 17, 2022 Pending
Array ( [id] => 19359283 [patent_doc_number] => 20240261317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASEUSING A SUBSTITUTED 4-FLUORO-2,5-DIHYDROFURANYL PHOSPHONIC ACID OR RELATED COMPOUND [patent_app_type] => utility [patent_app_number] => 18/561644 [patent_app_country] => US [patent_app_date] => 2022-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38440 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -66 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561644 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/561644
METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASEUSING A SUBSTITUTED 4-FLUORO-2,5-DIHYDROFURANYL PHOSPHONIC ACID OR RELATED COMPOUND May 16, 2022 Pending
Array ( [id] => 18649534 [patent_doc_number] => 20230295350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => CROSSLINKED DEXTRAN AND CROSSLINKED DEXTRAN-POLY ALPHA-1,3-GLUCAN GRAFT COPOLYMERS [patent_app_type] => utility [patent_app_number] => 17/744954 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19918 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744954 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/744954
CROSSLINKED DEXTRAN AND CROSSLINKED DEXTRAN-POLY ALPHA-1,3-GLUCAN GRAFT COPOLYMERS May 15, 2022 Abandoned
Array ( [id] => 19389280 [patent_doc_number] => 20240279150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => PROCESS FOR THE MANUFACTURE OF CARBOXYLIC ANHYDRIDE [patent_app_type] => utility [patent_app_number] => 18/563005 [patent_app_country] => US [patent_app_date] => 2022-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563005 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563005
PROCESS FOR THE MANUFACTURE OF CARBOXYLIC ANHYDRIDE May 10, 2022 Pending
Array ( [id] => 19359281 [patent_doc_number] => 20240261315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => ORAL SOLUTION BASED ON CITICOLINE AND NICOTINAMIDE FOR USE IN THE TREATMENT OF GLAUCOMA [patent_app_type] => utility [patent_app_number] => 18/560536 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560536 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/560536
ORAL SOLUTION BASED ON CITICOLINE AND NICOTINAMIDE FOR USE IN THE TREATMENT OF GLAUCOMA May 5, 2022 Pending
Array ( [id] => 19316646 [patent_doc_number] => 20240238186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides [patent_app_type] => utility [patent_app_number] => 18/557661 [patent_app_country] => US [patent_app_date] => 2022-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18557661 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/557661
Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides Apr 28, 2022 Pending
Array ( [id] => 19528255 [patent_doc_number] => 20240352157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => DISSOLUTION OF CHITOSAN IN APROTIC AQUEOUS MEDIUM COMPOSITION, PREPARATION METHODS AND BIOMEDICAL USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/495033 [patent_app_country] => US [patent_app_date] => 2022-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4380 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18495033 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/495033
DISSOLUTION OF CHITOSAN IN APROTIC AQUEOUS MEDIUM COMPOSITION, PREPARATION METHODS AND BIOMEDICAL USES THEREOF Apr 24, 2022 Pending
Array ( [id] => 19280100 [patent_doc_number] => 20240216573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => COMPOSITIONS COMPRISING CROSS-LINKED HYALURONIC ACID AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/286630 [patent_app_country] => US [patent_app_date] => 2022-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22941 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286630 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/286630
COMPOSITIONS COMPRISING CROSS-LINKED HYALURONIC ACID AND METHODS OF USE THEREOF Apr 12, 2022 Pending
Array ( [id] => 19217804 [patent_doc_number] => 20240182508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => AMPHIPATHIC COMPOUND, PREPARATION METHOD THEREFOR, AND SURFACTANT COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 18/283016 [patent_app_country] => US [patent_app_date] => 2022-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5573 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283016 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/283016
AMPHIPATHIC COMPOUND, PREPARATION METHOD THEREFOR, AND SURFACTANT COMPOSITION COMPRISING SAME Apr 10, 2022 Abandoned
Array ( [id] => 19263603 [patent_doc_number] => 20240207300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/284614 [patent_app_country] => US [patent_app_date] => 2022-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -121 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284614 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/284614
COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS Apr 6, 2022 Pending
Array ( [id] => 19263605 [patent_doc_number] => 20240207302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF [patent_app_type] => utility [patent_app_number] => 18/553666 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18183 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553666 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553666
ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF Mar 31, 2022 Pending
Array ( [id] => 19332594 [patent_doc_number] => 20240247024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE (NNMT) [patent_app_type] => utility [patent_app_number] => 18/553278 [patent_app_country] => US [patent_app_date] => 2022-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553278 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553278
INHIBITORS OF NICOTINAMIDE N-METHYL TRANSFERASE (NNMT) Mar 29, 2022 Pending
Array ( [id] => 19188154 [patent_doc_number] => 20240167067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => Cross-linkable xylans and methods of producing the same and their uses [patent_app_type] => utility [patent_app_number] => 18/283472 [patent_app_country] => US [patent_app_date] => 2022-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5078 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283472 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/283472
Cross-linkable xylans and methods of producing the same and their uses Mar 27, 2022 Pending
Array ( [id] => 19187859 [patent_doc_number] => 20240166772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => COMPOSITION COMPRISING CELLULOSE NANOFIBER AND LIGNIN OR COMPLEX OF THESE COMPONENTS, AND METHOD FOR PRODUCING LIGNOCELLULOSE-DERIVED MATERIAL [patent_app_type] => utility [patent_app_number] => 18/284318 [patent_app_country] => US [patent_app_date] => 2022-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284318 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/284318
COMPOSITION COMPRISING CELLULOSE NANOFIBER AND LIGNIN OR COMPLEX OF THESE COMPONENTS, AND METHOD FOR PRODUCING LIGNOCELLULOSE-DERIVED MATERIAL Mar 22, 2022 Pending
Array ( [id] => 19318629 [patent_doc_number] => 20240240172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => Process for Purifying Nucleic Acids, in particular in a Microfluidic Apparatus [patent_app_type] => utility [patent_app_number] => 18/562025 [patent_app_country] => US [patent_app_date] => 2022-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562025 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/562025
Process for Purifying Nucleic Acids, in particular in a Microfluidic Apparatus Mar 21, 2022 Pending
Array ( [id] => 19186237 [patent_doc_number] => 20240165150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION [patent_app_type] => utility [patent_app_number] => 18/551936 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551936 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/551936
COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION Mar 20, 2022 Abandoned
Array ( [id] => 19172565 [patent_doc_number] => 20240158539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => FUNCTIONALIZED CELLULOSE, METHOD OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE, PROCESS OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE USING AN ORGANIC ACID AND PROCESS FOR THE PRODUCTION OF A CELLULOSE WITH INCREASED HYDROPHOBICITY AND ARTICLE [patent_app_type] => utility [patent_app_number] => 18/282453 [patent_app_country] => US [patent_app_date] => 2022-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7655 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282453 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/282453
FUNCTIONALIZED CELLULOSE, METHOD OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE, PROCESS OF ENZYMATIC FUNCTIONALIZATION OF CELLULOSE USING AN ORGANIC ACID AND PROCESS FOR THE PRODUCTION OF A CELLULOSE WITH INCREASED HYDROPHOBICITY AND ARTICLE Mar 17, 2022 Abandoned
Array ( [id] => 19186235 [patent_doc_number] => 20240165148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 18/549042 [patent_app_country] => US [patent_app_date] => 2022-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5645 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549042 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549042
HYALURONIC ACID-CONJUGATED DIPALMITOYL PHOSPHATIDYL ETHANOLAMINE IN COMBINATION WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) FOR TREATING OR ALLEVIATING INFLAMMATORY DISEASES Mar 12, 2022 Pending
Array ( [id] => 19050853 [patent_doc_number] => 20240092822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/548711 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548711 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/548711
PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS Mar 1, 2022 Pending
Menu